| abstract |
(R) -5 -Methyl -4, 5-dihydro-pyrazole-1, 5 -dicarboxylic acid 1 - [ (4-chloro -phenyl) -amide] 5- {[2-f luoro-4- (2-oxo-2H-pyridin-1 -yl) -phenyl] -amide) pharmaceutical compositions, methods and methods of using the compound or pharmaceutical compositions thereof to treat diseases characterized by abnormal thrombosis in mammals. A crystalline form of (R) -5-Methyl-4, 5-dihydro-pyrazole-1, 5 -dicarboxylic acid 1-[(4- chloro- phenyl) -amide] 5- { [2-fluoro-4- (2-oxo-2H-pyridin-1 -yl) -phenyl] -amide} is also described. Formula (I): |